Sign In
Buy QQQA
$82.68
+1.78 (+2.20%)
At Close: Jun 03, 2026
ProShares Nasdaq-100 Dorsey Wright Momentum ETF (NASDAQ:QQQA) Short Interest Down 50.3% in February
04:31am, Friday, 27'th Feb 2026
ProShares Nasdaq-100 Dorsey Wright Momentum ETF (NASDAQ: QQQA - Get Free Report) was the target of a significant drop in short interest in February. As of February 13th, there was short interest total
ProShares Nasdaq-100 Dorsey Wright Momentum ETF (NASDAQ:QQQA) Trading Up 0.9% – Here’s Why
02:26am, Thursday, 11'th Dec 2025
ProShares Nasdaq-100 Dorsey Wright Momentum ETF (NASDAQ: QQQA - Get Free Report)'s stock price shot up 0.9% on Wednesday. The stock traded as high as $51.03 and last traded at $50.89. 1,247 shares tra
Invesco's QQQ Close to Getting a Modern Makeover
02:52pm, Friday, 05'th Dec 2025
When it comes to creating the Mount Rushmore of exchange-traded funds (ETFs), the Invesco QQQ ETF (QQQ) has to be in the conversation. Since 1999, the fund has been the go-to option when it comes to g
Nonstop Nasdaq
01:10pm, Wednesday, 24'th Jan 2024
The mega-cap Tech-heavy Nasdaq 100 is up nearly 1% today as of this writing, which leaves it up 4.5% already in 2024. The Nasdaq 100 is now up 64% during its current bull market that began on 12/28/22
ETFs to Add Gains on Netflix Q2 Solid Subscriber Growth
12:54pm, Thursday, 20'th Jul 2023
Netflix (NFLX) topped earnings estimates while lagging on revenues. It also provided a downbeat revenue guidance.
Netflix Target Price Up Ahead of Q2 Earnings: ETFs in Focus
01:35pm, Tuesday, 18'th Jul 2023
Netflix shares rallied to their highest price in more than a year on Jul 17, after a series of analysts lifted the target price on the stock ahead of Q2 earnings.
What's in Store for Netflix ETFs in Q1?
12:57pm, Monday, 17'th Apr 2023
Netflix saw no earnings estimate revision over the past 30 days for the to-be-reported quarter. It's earnings surprise history is impressive.
An ETF That Focuses on the Leading Outperformers in the Nasdaq
05:41pm, Thursday, 21'st Oct 2021
Exchange traded fund investors can consider a unique approach to momentum investing that may make a big difference to a portfolio and help unlock the outperformance potential of companies in the Nasda
Unlocking the Nasdaq-100's Outperformance Potential
06:56pm, Wednesday, 20'th Oct 2021
The Nasdaq-100 has become a leading index for investors looking to track some of the hottest growing companies in the world. But is there a way to possibly identify the best-performing companies?
Marriott Releases Annual ESG Report, Highlights Community Engagement
10:54am, Monday, 20'th Sep 2021
Marriott International Inc. recently released its yearly ESG report, the 2021 Serve 360 Report, which details and catalogues efforts made in 2020 towards environmentalism, social engagement, and gover
QQQA Picks the Best Momentum Companies as the Nasdaq Continues to Hit Records
11:13am, Friday, 27'th Aug 2021
The Nasdaq closed at another record high on Wednesday as markets continue to ride the bevy of boosts from recent favorable government approvals, reports The Wall Street Journal. Full approval of the P
‘QQQA' Won't Miss Its Shot as Pfizer and Moderna Set to Profit with Boosters
02:30pm, Friday, 13'th Aug 2021
Analysts and healthcare investors estimate that Moderna and Pfizer will earn billions from Covid-19 boosters in the coming months and set the stage for a booster market that would be similar to the $6
ETF Offers Momentum Twist On Large Cap Growth
01:13am, Monday, 26'th Jul 2021
ProShares' new ETF offers a momentum take on the stocks of the Nasdaq-100.
The InvestorPlace Q&A: Embrace Investing in Momentum With the ProShares QQQA ETF
02:20pm, Wednesday, 07'th Jul 2021
Investors should consider the QQQA exchange-traded fund in order to diversify their portfolio with a solid investing philosophy. The post The InvestorPlace Q&A: Embrace Investing in Momentum With the
Momentum Is Cool for Now, but This New ETF Could Be Heating Up
03:15pm, Friday, 18'th Jun 2021
High beta and value stocks are outperforming the S&P 500 this year while momentum names are being left behind. For patient investors, that scenario could prove inviting when it comes to evaluating the
